Adagio Medical Holdings, Inc. (ADGM) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Adagio Medical Holdings, Inc. on August 14, 2026, regarding an event dated August 13, 2026. The Company is an emerging growth company listed on the Nasdaq Capital Market under the symbol "ADGM."
Key Financial Metrics
The filing references the Company's financial position as of June 30, 2026, based on its Quarterly Report on Form 10-Q:
- Stockholders' Equity: $(415,000) (Negative equity).
- Market Value of Listed Securities: Below the $35 million alternative standard.
- Net Income: Below the $500,000 alternative standard for the most recent fiscal year and two of the last three fiscal years.
The filing does not provide specific values for revenue, operating cash flow, or debt levels.
Material Changes and Listing Status
On August 13, 2026, the Company received a deficiency letter from Nasdaq notifying it of non-compliance with Listing Rule 5550(b)(1), which requires a minimum stockholders' equity of $2,500,000. The Company currently fails to meet this requirement and also fails to meet the alternative quantitative standards for continued listing.
Outlook, Risks, and Management Commentary
Compliance Timeline: The Company has 45 calendar days, until September 28, 2026, to submit a Compliance Plan to regain compliance. If accepted, Nasdaq may grant an additional 180-day extension to restore equity levels.
Management Intent: Management intends to submit the Compliance Plan by the deadline and is evaluating options to regain compliance.
Risks and Contingencies:
- Delisting Risk: Failure to regain compliance could result in delisting from the Nasdaq Capital Market.
- Liquidity and Going Concern: The filing highlights risks related to the Company's current liquidity position and the need for additional financing to support operations and fund planned programs.
- Forward-Looking Uncertainty: Actual results may differ materially from expectations regarding the ability to obtain financing and regain listing status.
Key Facts for Investor Verification
- Verify the specific details of the Compliance Plan once submitted by September 28, 2026.
- Review the Form 10-Q for the quarter ended June 30, 2026, for full details on the negative equity position and liquidity status.
- Monitor announcements regarding the acceptance or rejection of the Compliance Plan by Nasdaq staff.
- Assess the Company's ability to secure additional capital to address the negative equity and fund ongoing operations.